18F-FDG PET/CT 诊断脊柱感染的系统综述与双变量 meta 分析
18F-FDG PET/CT 诊断脊柱感染的合并敏感度94.8%、特异度91.4%,可作为MRI不可行或结果不确定时的补充手段。
要点
- 18F-FDG PET/CT 诊断脊柱感染合并敏感度94.8%、特异度91.4%。
- 合并LR+为4.7、LR-为0.11、DOR为63.4,未见明显异质性或发表偏倚。
- MRI不可行、不可诊断或结论不确定时,可考虑18F-FDG PET/CT。
核心结论
- 18F-FDG PET/CT 在脊柱感染中诊断性能很好,可用于MRI不可行或结果不确定的患者。
- 多项研究强调其在评估脊柱感染治疗反应方面的价值。
- 仍需更大规模多中心前瞻性研究与成本效果分析。
研究设计与样本
- 系统综述与双变量 meta 分析,检索截至2019年2月 PubMed/MEDLINE 与 Cochrane 图书馆数据库。
- 定量分析按每检查为基础计算合并敏感度、特异度、似然比与诊断比值比。
主要发现
- 疑似脊柱感染患者中,18F-FDG PET/CT 合并敏感度为94.8%(95%CI 88.9-97.6%)。
- 合并特异度为91.4%(95%CI 78.2-96.9%)。
- 合并LR+为4.7(95%CI 2.9-7.7),合并LR-为0.11(95%CI 0.07-0.16)。
- 合并DOR为63.4(95%CI 28.9-139)。
- 未发现显著异质性或发表偏倚。
关键数值与推荐
- 疑似脊柱感染:18F-FDG PET/CT 敏感度94.8%(95%CI 88.9-97.6%)、特异度91.4%(95%CI 78.2-96.9%)。
- 合并LR+ 4.7(95%CI 2.9-7.7)、LR- 0.11(95%CI 0.07-0.16)、DOR 63.4(95%CI 28.9-139)。
临床怎么用
- 对疑似脊柱感染且MRI不可行、不可诊断或结论不确定者,可考虑18F-FDG PET/CT 辅助诊断。
- 可参考18F-FDG PET/CT 评估脊柱感染的治疗反应。
局限性
- 需要更大规模的多中心前瞻性研究进一步验证。
- 尚需成本效果分析支持临床推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diagnosis of spinal infection (SI) is challenging and usually requires multiple tests. We aimed to perform a systematic review and a bivariate meta-analysis on the diagnostic role of 18F-FDG PET/CT in patients with SI. METHODS: A comprehensive literature search of studies published through February 2019 in PubMed/MEDLINE and Cochrane library databases was carried out. Studies investigating the diagnostic performance of 18F-FDG PET/CT in patients with SI were eligible for inclusion in the qualitative analysis. For the quantitative analysis, pooled sensitivity, specificity, positive and negative likelihood ratio (LR+ and LR-) and diagnostic odds ratio (DOR) of 18F-FDG PET/CT in patients with suspected SI were calculated on a per examination-based analysis. Pooled data were presented with 95% confidence intervals (95% CI). RESULTS: Twenty-six articles (833 patients) using 18F-FDG PET/CT were eligible for the qualitative analysis. Twelve studies (396 patients) were selected for the meta-analysis. Overall, 18F-FDG PET/CT demonstrated a very good diagnostic performance in patients with SI and several studies underlined the value of 18F-FDG PET/CT in assessing the response to treatment. The bivariate meta-analysis on 18F-FDG PET/CT in patients with suspected SI provided the following results: sensitivity 94.8% (95% CI 88.9-97.6%) and specificity 91.4% (95% CI 78.2-96.9%). The pooled LR+, LR- and DOR were 4.7 (95% CI 2.9-7.7), 0.11 (95% CI 0.07-0.16) and 63.4 (95% CI 28.9-139), respectively. No significant heterogeneity or publication bias was found. CONCLUSION: 18F-FDG PET/CT demonstrated a very good diagnostic performance in patients with SI and can be used in patients in which MRI cannot be performed or is non-diagnostic or inconclusive. Several studies underlined the value of 18F-FDG PET/CT in assessing the response to treatment in patients with SI. Overall, larger multicentre and prospective studies and cost-effectiveness analyses are warranted.
引用
- Treglia G, Pascale M, Lazzeri E, et al. Diagnostic performance of 18F-FDG PET/CT in patients with spinal infection: a systematic review and a bivariate meta-analysis. Eur J Nucl Med Mol Imaging. 2019. PMID: 31729539. doi:10.1007/s00259-019-04571-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。